ArticleJournal of asthma and allergy2024

Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study.

Daiana Stolz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.